It is possible to consider giving COVID-19 patients experiencing cytokine storm a P2X7 blocker along with supplemental ATP to keep the putative pathway postulated by di Virgilio et al. in check while simultaneously letting these patients experience the systemic benefits of ATP pool replenishment. The gene discussed is P2RX7; the disease is COVID-19.